Research Awards for November 2011
Ariizumi, Kiyoshi, NIH, DC-HIL in Cutaneous Immunity, $353,059; Bezprozvanny, Ilya, NIH, Deranged Calcium Signaling and Polyglutamine Expansion Disorders, $302,913; Burgess, Shawn, NIH, Factors Controlling Metabolic Flux in Liver by NMR Isotopomer Analysis, $276,976; Cavanagh, Dwight, Jaeb Ctr. for Health/NIH, Cornea Donor Study, $75; Elliott, Jeffrey, NIH, Mechanisms of SOD1 Toxicity in ALS, $272,621; Greene, Robert, NIH, Dopamine Modulation of NMDA Receptor Synaptic Responses, $283,272; Hansen, Eric, NIH, Surface Proteins of Moraxella Catarrhalis, $311,599; He, Yu-Guang, Emmes Corp./NIH, Age-Related Eye Disease Study 2 (AREDS2), $4,734; Holper, Elizabeth, Univ. of Toledo/NIH, CORAL - Cardiovascular Outcomes in Renal Atherosclerotic Lesions, $1,595; Hsia, Connie, NIH, Signals for Post-Pneumonectomy Compensatory Lung Growth, $385,090; Idris, Ahamed, Univ. of Washington/NIH, ROC Protocols; PROPHET/BLAST/RESCUE Studies, $6,000.
Lee, William, Food and Drug Administration, Access to Serious Hepatotoxicity Surveillance Database, $158,378; Lin, Rueyling, NIH, Transcriptional Regulation by Wnt Effector POP-1, $284,383; Malter, James, NIH, Pin1 Regulation of Prosurvival Signaling in Eosinophils, $196,548; Markham, David, Univ. of Pittsburgh/NIH, Immune Activation and Myocardial Recovery in Peripartum Cardiomyopathy - ARRA Stimulus Funding, $700; Mendell, Joshua, NIH, c-Myc-Regulated microRNAs in Normal and Pathologic Cellular Physiology, $223,564; Mendelson, Carole, NIH, Mechanisms in the Regulation of SP-A Gene Expression, $430,985; Miller, David, Gynecologic Oncology Group/NIH, Gynecologic Oncology Group Studies (Per Capita), $39,820; Nedzi, Lucien, American Coll. of Radiology/NIH, Radiation Therapy Oncology Group (RTOG); Agreement #5915, $3,000; Nesbitt, Shawna, Minneapolis Med. Research Fndtn./NIH, ASPirin in Reducing Events in Elderly, $6,600.
Olson, Eric, NIH, Deciphering Regulatory Circuit for Myocardial Metabolism and Energy Homeostasis, $555,188; Powell, Craig, NIH, Neuroligin Function in vivo: Implications for Autism and Mental Retardation, $349,718; Ranganathan, Rama, NIH, Mechanistic Analysis of Dynamic Scaffolding in Cellular Signaling Network, $314,746; Timaran, Carlos, Univ. of Medicine & Dentistry of N.J./NIH, Carotid Revascularization Endarterectomy vs. Stent Trial (CREST), $7,900; Winick, Naomi, Natl. Childhood Cancer Fndtn./NIH, COG Phase 1 Pilot Consortium PCR; #1021, $20,300; Wright, Woodring, NIH, Manipulating Telomerase Alternative Splicing for Cancer Therapy, $296,232; Yanagisawa, Hiromi, NIH, Loss of Matrix Regulation and Aortic Aneurysm Development in Vivo, $357,503; Zimmern, Philippe, New England Research Institute/NIH, Urinary Incontinence Treatment Network (UITN); Site 171, $5,320.
Hsieh, Jer-Tsong, UT Dallas/CPRIT, Development of Small Molecular Mimicking Pro-Apoptotic Proteins for Treating Prostate Cancer, $86,434; Inrig, Jula, Amer Soc of Nephrology, Mechanisms of Intradialytic Hypertension and Potential Role of Dialysate Sodium (Fellow Catherine Kim - 1005), $6,500; Morrison, Sean (Fellow R. Yue), Damon Runyon Cancer Research Foundation, Functional Analysis of Leptin Receptor Signaling in Hamatopoietic Stem Cells and Perivascular Niche, $52,000; Noe, Carl, Boston Scientific Corp., Boston Scientific Fellowship, $20,000; Powell, Craig (Fellow M. Kouser), Autism Speaks, Shank3 Mutant Characterization in Vivo, $28,000; Wiebe, Deborah (Fellow A. Croom), Timberlawn Foundation, Illness Perceptions of Patients with Advance Stage Cancer and Their Partners, $14,000.
Industry Sponsored Awards,
dollar amounts not available
Anderson, Larry, Ph3 Trial of Lenalidomide/Dexamethasone w/wo Elotuzumab in Relapsed or Refractory Multiple Myeloma; Aquino, Victor, Ph2 Study of Preemptive Trtmt with CMX001 for Prevention of Adenovirus Disease Following Hematopoietic Stem Cell Transplantation (ADV HALT Trial); de Lemos, James, Cardiac Biomarker of hsTnI in Two Clinical Cohorts; Dowell, Jonathan, Ph3 Study of NGR-hTNF Plus Best Investigator Choice (BIC) vs Placebo Plus BIC in Prev Trtd Pts w Advanced Malignant Pleural Mesothelioma (MPM); Garg, Abhimanyu, Molecular Characterization of Familial Hypercholesterolemia; Gerber, David, Ph1 Dose Escal Study of ARQ 761 (Beta-Lapachone) in Adult Pts w Advanced Solid Tumors; Lee, William, Ph2b Trial Eval Response Guided Therapy w GS-5885 Alone or in Comb w GS-9451 w Peginterferon Alfa 2a and Ribavirin in Trtmt Naive Sjs w Chronic Genotype 1 Hep C Virus Infection; Takahashi, Masaya, Optimization of Clinical Imaging Protocol at High Field MRI; Verma, Udit, Ph3 Study of S-1 and Cisplatin Compared w 5-FU and Cisplatin in Pts w Metastatic Diffuse Gastric Cancer Prev Untrtd w Chemotherapy; Yopp, Adam, Ph2 Trial of Gemcitabine w/wo Bavituximab in Pts w Prev Untreated Stage IV Pancreatic Cancer.